Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia-Reference-Cited by-同舟云学术

Use of Adjuvant Endocrine Therapy Among Post-Menopausal Breast Cancer Patients in Malaysia

Published:2021-02 Issue: Volume:Volume 15 Page:227-235
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Saiful Bahri Athirah,Tuan Mahmood Tuan Mazlelaa,Abdul-Aziz Siti Azdiah,Makmor-Bakry Mohd^ORCID,Mohamed Shah Noraida^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference28 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Azizah AM, Hashimah B, Nirmal K, et al. Malaysian National Cancer Report (MNCR) 2012–2016. Malaysia: Ministry of Health; 2019. Available from: https://drive.google.com/file/d/1BuPWrb05N2Jez6sEP8VM5r6JtJtlPN5W/view. Accessed January 21, 2021.

3. Malaysia clinical practice guidelines: management of breast cancer. Malaysia: Ministry of Health; 2010. Available from: https://www.moh.gov.my/moh/attachments/6915.pdf. Accessed January 21, 2021.

4. Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

5. Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Malaysian Medicinal Plants with Potential Anticancer Activity;Malaysian Applied Biology;2023-03-31

2. Mapping Breast Cancer Research in Malaysia: A Scientometric Analysis;Medicine & Health;2022-12-14

3. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review;The Breast;2022-04

4. Validation and reliability of the Bahasa Malaysia language version of the Acceptance of Illness Scale among Malaysian patients with cancer;PLOS ONE;2021-09-29